nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

18.05.2016 | Original Paper

The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

verfasst von: Steffen Moritz, Fabrice Berna, Susanne Jaeger, Stefan Westermann, Matthias Nagel

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Clinicians and patients differ concerning the goals of treatment. Eighty individuals with schizophrenia were assessed online about which symptoms they consider the most important for treatment, as well as their experience with different interventions. Treatment of affective and neuropsychological problems was judged as more important than treatment of positive symptoms (p < 0.005). While most individuals had experience with Occupational and Sports Therapy, only a minority had received Cognitive-Behavioral Therapy, Family Therapy, and Psychoeducation with family members before. Patients appraised Talk, Psychoanalytic, and Art Therapy as well as Metacognitive Training as the most helpful treatments. Clinicians should carefully take into consideration patients’ preferences, as neglect of consumers’ views may compromise outcome and adherence to treatment.

Way BB, Banks S (2001) Clinical factors related to admission and release decisions in psychiatric emergency services. Psychiatr Serv 52:214–218CrossRefPubMed

Addington DE, Beck C, Wang J et al (2010) Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatr Serv 61:483–488. doi:10.1176/appi.ps.61.5.483 CrossRefPubMed

Kuhnigk O, Slawik L, Meyer J et al (2012) Valuation and attainment of treatment goals in schizophrenia: perspectives of patients, relatives, physicians, and payers. J Psychiatr Pract 18:321–328. doi:10.1097/01.pra.0000419816.75752.65 CrossRefPubMed

Peralta V, Cuesta MJ (2009) Characterization of affective domains within the nonaffective psychotic disorders. Schizophr Res 111:61–69. doi:10.1016/j.schres.2009.03.008 CrossRefPubMed

Cotton SM, Lambert M, Schimmelmann BG et al (2012) Depressive symptoms in first episode schizophrenia spectrum disorder. Schizophr Res 134:20–26. doi:10.1016/j.schres.2011.08.018 CrossRefPubMed

Moritz S, Cludius B, Hottenrott B et al (2015) Mindfulness and relaxation treatment reduce depressive symptoms in individuals with psychosis. Eur Psychiatry. doi:10.1016/j.eurpsy.2015.05.002 PubMed

Van der Valk R, Van de Waerdt S, Meijer CJ et al (2013) Feasibility of mindfulness-based therapy in patients recovering from a first psychotic episode: a pilot study. Early Interv Psychiatry 7:64–70. doi:10.1111/j.1751-7893.2012.00356.x CrossRefPubMed

Chadwick P (2014) Mindfulness for psychosis. Br J Psychiatry 204:333–334. doi:10.1192/bjp.bp.113.136044 CrossRefPubMed

Khoury B, Lecomte T, Fortin G et al (2013) Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev 33:763–771. doi:10.1016/j.cpr.2013.05.005 CrossRefPubMed

10.

Hasson-Ohayon I, Kravetz S, Levy I, Roe D (2009) Metacognitive and interpersonal interventions for persons with severe mental illness: theory and practice. Isr J Psychiatry Relat Sci 46:141–148PubMed

11.

White R, Gumley A, McTaggart J et al (2011) A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis. Behav Res Ther 49:901–907. doi:10.1016/j.brat.2011.09.003 CrossRefPubMed

12.

Johnson DP, Penn DL, Fredrickson BL et al (2009) Loving-kindness meditation to enhance recovery from negative symptoms of schizophrenia. J Clin Psychol 65:499–509. doi:10.1002/jclp.20591 CrossRefPubMed

13.

Moritz S, Rietschel L, Veckenstedt R, Bohn F, Schneider BC, Lincoln TM, Karow A (2015) The other side of “madness”: frequencies of positive and ambivalent attitudes towards prominent positive symptoms in psychosis. Psychosis 7:14–24. doi:10.1080/17522439.2013.865137 CrossRef

14.

Moritz S, Favrod J, Andreou C et al (2013) Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophr Bull 39:917–922. doi:10.1093/schbul/sbs005 CrossRefPubMed

15.

Lasalvia A, Boggian I, Bonetto C et al (2012) Multiple perspectives on mental health outcome: needs for care and service satisfaction assessed by staff, patients and family members. Soc Psychiatry Psychiatr Epidemiol 47:1035–1045. doi:10.1007/s00127-011-0418-0 CrossRefPubMed

16.

Hamann J, Mendel R, Cohen R et al (2009) Psychiatrists’ use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv 60:1107–1112. doi:10.1176/appi.ps.60.8.1107 CrossRefPubMed

17.

Rosenheck R, Stroup S, Keefe RSE et al (2005) Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry 187:529–534. doi:10.1192/bjp.187.6.529 CrossRefPubMed

18.

Byrne R, Davies L, Morrison AP (2010) Priorities and preferences for the outcomes of treatment of psychosis: a service user perspective. Psychosis 2:210–217. doi:10.1080/17522430903456913 CrossRef

19.

Berry K, Haddock G (2008) The implementation of the NICE guidelines for schizophrenia: barriers to the implementation of psychological interventions and recommendations for the future. Psychol Psychother 81:419–436. doi:10.1348/147608308X329540 CrossRefPubMed

20.

Bechdolf A, Klingberg S (2014) Psychotherapie bei schizophrenen Störungen: kein Evidenz-, sondern ein Implementierungsproblem [Psychotherapy of schizophrenia: Not a problem of evidence, but a problem of implementation]. Psychiatr Prax 41:8–10. doi:10.1055/s-0033-1359957 CrossRefPubMed

21.

Puschner B, Vauth R, Jacobi F, Becker T (2006) Bedeutung von Psychotherapie in der Versorgung von Menschen mit schizophrenen Störungen in Deutschland: wie evidenzbasiert ist die Praxis? [Importance of psychotherapy in the health care of individuals with schizophrenia in Germany]. Nervenarzt 77:1301–1309. doi:10.1007/s00115-006-2102-2 CrossRefPubMed

22.

Haddock G, Eisner E, Boone C et al (2014) An investigation of the implementation of NICE-recommended CBT interventions for people with schizophrenia. J Ment Health 23:162–165. doi:10.3109/09638237.2013.869571 CrossRefPubMed

23.

Rummel-Kluge C, Pitschel-Walz G, Bäuml J, Kissling W (2006) Psychoeducation in schizophrenia–results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 32:765–775. doi:10.1093/schbul/sbl006 CrossRefPubMedPubMedCentral

24.

Bundespsychotherapeutenkammer [Chamber of German Psychotherapists] (2014) BPtK-Studie zur stationären Versorgung psychisch kranker Menschen. Ergebnisse einer Befragung der in Krankenhäusern angestellten Psychotherapeuten [Study of the German chamber of psychotherapists about inpatient care in people with psychological disorders]. Bundespsychotherapeutenkammer, Berlin (Germany)

25.

Prytys M, Garety PA, Jolley S et al (2011) Implementing the NICE guideline for schizophrenia recommendations for psychological therapies: a qualitative analysis of the attitudes of CMHT staff. Clin Psychol Psychother 18:48–59. doi:10.1002/cpp.691 CrossRefPubMed

26.

Jaeger S, Wachter C, Steiner T (2014) Nicht-medikamentöse therapeutische Maßnahmen bei Schizophrenie—Was kennen Patienten? Was finden sie hilfreich? [Non-pharmacological therapeutic measures in schizophrenia—what do patients know? What do they judge as helpful?] DGPPN Kongress 2014

27.

Stefanis NC, Hanssen M, Smirnis NK et al (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358. doi:10.1017/S0033291701005141 CrossRefPubMed

28.

Moritz S, Van Quaquebeke N, Lincoln TM et al (2013) Can we trust the internet to measure psychotic symptoms? Schizophr Res Treat 2013:457010. doi:10.1155/2013/457010

29.

Montag C, Haase L, Seidel D et al (2014) A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity. PLoS ONE 9:e112348. doi:10.1371/journal.pone.0112348 CrossRefPubMedPubMedCentral

30.

Deutsche Gesellschaft für Psychiatrie P und N (DGPPN) (eds) (2006) S3 Praxisleitlinien. Band 1 Behandlungsleitlinie Schizophrenie [S3 guidelines. Volume 1. Treatment guideline for schizophrenia]. Steinkopff, Darmstadt

31.

Gosling SD, Vazire S, Srivastava S, John OP (2004) Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. Am Psychol 59:93–104. doi:10.1037/0003-066X.59.2.93 CrossRefPubMed

32.

Schneider F, Falkai P, Maier W (2012) Psychiatrie 2020. Perspektiven, Chancen und Herausforderungen [Psychiatry 2020. Perspectives, chance and challenges]. Springer, Heidelberg

33.

Sun SX, Liu GG, Christensen DB, Fu AZ (2007) Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin 23:2305–2312. doi:10.1185/030079907X226050 CrossRefPubMed

34.

Emsley R, Chiliza B, Asmal L, Harvey BH (2013) The nature of relapse in schizophrenia. BMC Psychiatry 13:50. doi:10.1186/1471-244X-13-50 CrossRefPubMedPubMedCentral

35.

Eiring Ø, Landmark BF, Aas E et al (2015) What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders. BMJ Open 5:e007848. doi:10.1136/bmjopen-2015-007848 CrossRefPubMedPubMedCentral

36.

Naber D, Lambert M (2013) Should we listen and talk more to our patients? World Psychiatry 12:237–238. doi:10.1002/wps.20066 CrossRefPubMedPubMedCentral

37.

Suzuki T, Uchida H, Takeuchi H et al (2014) A review on schizophrenia and relapse–a quest for user-friendly psychopharmacotherapy. Hum Psychopharmacol 29:414–426. doi:10.1002/hup.2421 CrossRefPubMed

38.

Westermann S, Cavelti M, Heibach E, Caspar F (2015) Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia. Front Psychol 6:1294. doi:10.3389/fpsyg.2015.01294 CrossRefPubMedPubMedCentral

Titel: The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis
verfasst von: Steffen Moritz
Fabrice Berna
Susanne Jaeger
Stefan Westermann
Matthias Nagel
Publikationsdatum: 18.05.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 4/2017
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-016-0694-5

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Psychopathological and demographic characteristics of hallucinating patients with schizophrenia and schizoaffective disorder: an analysis based on AMDP data

Treatment recommendations for schizophrenia, major depression and alcohol dependence and stigmatizing attitudes of the public: results from a German population survey

The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study

Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies